Small-Molecule Inhibitors of the Coronavirus Spike: ACE2 Protein–Protein Interaction as Blockers of Viral Attachment and Entry for SARS-CoV-2
出版年份 2021 全文链接
标题
Small-Molecule Inhibitors of the Coronavirus Spike: ACE2 Protein–Protein Interaction as Blockers of Viral Attachment and Entry for SARS-CoV-2
作者
关键词
-
出版物
ACS Infectious Diseases
Volume -, Issue -, Pages -
出版商
American Chemical Society (ACS)
发表日期
2021-05-13
DOI
10.1021/acsinfecdis.1c00070
参考文献
相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。- Methylene Blue Inhibits the SARS-CoV-2 Spike–ACE2 Protein-Protein Interaction–a Mechanism that can Contribute to its Antiviral Activity Against COVID-19
- (2021) Damir Bojadzic et al. Frontiers in Pharmacology
- Generation of SARS-CoV-2 Spike Pseudotyped Virus for Viral Entry and Neutralization Assays: A 1-Week Protocol
- (2021) Jose Manuel Condor Capcha et al. Frontiers in Cardiovascular Medicine
- SARS-CoV-2 501Y.V2 escapes neutralization by South African COVID-19 donor plasma
- (2021) Constantinos Kurt Wibmer et al. NATURE MEDICINE
- Chloroquine for the 2019 novel coronavirus SARS-CoV-2
- (2020) Philippe Colson et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Composition and divergence of coronavirus spike proteins and host ACE2 receptors predict potential intermediate hosts of SARS-CoV-2
- (2020) Zhixin Liu et al. JOURNAL OF MEDICAL VIROLOGY
- Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine
- (2020) Wanbo Tai et al. Cellular & Molecular Immunology
- The Science Underlying COVID-19: Implications for the Cardiovascular System
- (2020) Peter P. Liu et al. CIRCULATION
- The many faces of the anti-COVID immune response
- (2020) Santosha A. Vardhana et al. JOURNAL OF EXPERIMENTAL MEDICINE
- The many estimates of the COVID-19 case fatality rate
- (2020) Dimple D Rajgor et al. LANCET INFECTIOUS DISEASES
- Human neutralizing antibodies elicited by SARS-CoV-2 infection
- (2020) Bin Ju et al. NATURE
- Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor
- (2020) Jun Lan et al. NATURE
- A SARS-CoV-2 protein interaction map reveals targets for drug repurposing
- (2020) David E. Gordon et al. NATURE
- Cell entry mechanisms of SARS-CoV-2
- (2020) Jian Shang et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Cytokine release syndrome in severe COVID-19
- (2020) John B. Moore et al. SCIENCE
- Rapid repurposing of drugs for COVID-19
- (2020) R. Kiplin Guy et al. SCIENCE
- A noncompeting pair of human neutralizing antibodies block COVID-19 virus binding to its receptor ACE2
- (2020) Yan Wu et al. SCIENCE
- Estimating the burden of SARS-CoV-2 in France
- (2020) Henrik Salje et al. SCIENCE
- A human monoclonal antibody blocking SARS-CoV-2 infection
- (2020) Chunyan Wang et al. Nature Communications
- Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV
- (2020) Xiuyuan Ou et al. Nature Communications
- Sirtuin 1 Inhibiting Thiocyanates (S1th)—A New Class of Isotype Selective Inhibitors of NAD+ Dependent Lysine Deacetylases
- (2020) Nathalie Wössner et al. Frontiers in Oncology
- Structural Basis of the SARS-CoV-2/SARS-CoV Receptor Binding and Small-Molecule Blockers as Potential Therapeutics
- (2020) Hariharan Sivaraman et al. Annual Review of Pharmacology and Toxicology
- Suramin Inhibits SARS-CoV-2 Infection in Cell Culture by Interfering with Early Steps of the Replication Cycle
- (2020) Clarisse Salgado-Benvindo et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Discovering small-molecule therapeutics against SARS-CoV-2
- (2020) Vaibhav Tiwari et al. DRUG DISCOVERY TODAY
- Immune checkpoint inhibitors: a physiology-driven approach to the treatment of coronavirus disease 2019
- (2020) Serena Di Cosimo et al. EUROPEAN JOURNAL OF CANCER
- The pathogenesis and treatment of the `Cytokine Storm' in COVID-19
- (2020) Qing Ye et al. JOURNAL OF INFECTION
- COVID-19: Drug Targets and Potential Treatments
- (2020) Carmen Gil et al. JOURNAL OF MEDICINAL CHEMISTRY
- Inhibitors of SARS-CoV-2 Entry: Current and Future Opportunities
- (2020) Siyu Xiu et al. JOURNAL OF MEDICINAL CHEMISTRY
- A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2–spike protein–protein interaction
- (2020) Chee Wah Tan et al. NATURE BIOTECHNOLOGY
- Candidate drugs against SARS-CoV-2 and COVID-19
- (2020) Dwight L. McKee et al. PHARMACOLOGICAL RESEARCH
- Antibody cocktail to SARS-CoV-2 spike protein prevents rapid mutational escape seen with individual antibodies
- (2020) Alina Baum et al. SCIENCE
- Structural basis for neutralization of SARS-CoV-2 and SARS-CoV by a potent therapeutic antibody
- (2020) Zhe Lv et al. SCIENCE
- Broad neutralization of SARS-related viruses by human monoclonal antibodies
- (2020) Anna Z. Wec et al. SCIENCE
- Structural basis of a shared antibody response to SARS-CoV-2
- (2020) Meng Yuan et al. SCIENCE
- How does SARS-CoV-2 cause COVID-19?
- (2020) Nicholas J. Matheson et al. SCIENCE
- A single unified model for fitting simple to complex receptor response data
- (2020) Peter Buchwald Scientific Reports
- Methylene blue inhibits the replication of SARS-Cov-2 in vitro
- (2020) Mathieu Gendrot et al. INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS
- Cytokine release syndrome in COVID-19: Innate immune, vascular, and platelet pathogenic factors differ in severity of disease and sex
- (2020) Aaron C. Petrey et al. JOURNAL OF LEUKOCYTE BIOLOGY
- Autoantibodies against type I IFNs in patients with life-threatening COVID-19
- (2020) Paul Bastard et al. SCIENCE
- COVID-19: Infection or Autoimmunity
- (2020) Timothy Icenogle Frontiers in Immunology
- Antibody-like proteins that capture and neutralize SARS-CoV-2
- (2020) T. Kondo et al. Science Advances
- Repurposed Antiviral Drugs for Covid-19 — Interim WHO Solidarity Trial Results
- (2020) NEW ENGLAND JOURNAL OF MEDICINE
- Structural basis for human coronavirus attachment to sialic acid receptors
- (2019) M. Alejandra Tortorici et al. NATURE STRUCTURAL & MOLECULAR BIOLOGY
- CD40-targeting KGYY15 peptides do not efficiently block the CD40–CD40L interaction
- (2019) Damir Bojadzic et al. DIABETOLOGIA
- New Author Guidelines for Displaying Data and Reporting Data Analysis and Statistical Methods in Experimental Biology
- (2019) Martin C. Michel et al. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS
- Small Molecules Drive Big Improvements in Immuno-Oncology Therapies
- (2018) Bayard R. Huck et al. ANGEWANDTE CHEMIE-INTERNATIONAL EDITION
- Experimental design and analysis and their reporting II: updated and simplified guidance for authors and peer reviewers
- (2018) Michael J Curtis et al. BRITISH JOURNAL OF PHARMACOLOGY
- Toward Small-Molecule Inhibition of Protein–Protein Interactions: General Aspects and Recent Progress in Targeting Costimulatory and Coinhibitory (Immune Checkpoint) Interactions
- (2018) Damir Bojadzic et al. CURRENT TOPICS IN MEDICINAL CHEMISTRY
- Efficacy and safety of primaquine and methylene blue for prevention of Plasmodium falciparum transmission in Mali: a phase 2, single-blind, randomised controlled trial
- (2018) Alassane Dicko et al. LANCET INFECTIOUS DISEASES
- Design, Synthesis, and Evaluation of Novel Immunomodulatory Small Molecules Targeting the CD40–CD154 Costimulatory Protein-Protein Interaction
- (2018) Damir Bojadzic et al. MOLECULES
- Postmarket Safety Events Among Novel Therapeutics Approved by the US Food and Drug Administration Between 2001 and 2010
- (2017) Nicholas S. Downing et al. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION
- Phantom PAINS: Problems with the Utility of Alerts for Pan-Assay INterference CompoundS
- (2017) Stephen J. Capuzzi et al. Journal of Chemical Information and Modeling
- Beyond the Rule of 5: Lessons Learned from AbbVie’s Drugs and Compound Collection
- (2017) David A. DeGoey et al. JOURNAL OF MEDICINAL CHEMISTRY
- Small-Molecule Inhibitors of the CD40–CD40L Costimulatory Protein–Protein Interaction
- (2017) Jinshui Chen et al. JOURNAL OF MEDICINAL CHEMISTRY
- Inhibitors of HIV-1 Attachment: The Discovery and Development of Temsavir and its Prodrug Fostemsavir
- (2017) Nicholas A. Meanwell et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Current State of Peptide Drug Discovery: Back to the Future?
- (2017) Antoine Henninot et al. JOURNAL OF MEDICINAL CHEMISTRY
- The Ecstasy and Agony of Assay Interference Compounds
- (2017) Courtney Aldrich et al. JOURNAL OF MEDICINAL CHEMISTRY
- Targeted protein degradation by PROTACs
- (2017) Taavi K. Neklesa et al. PHARMACOLOGY & THERAPEUTICS
- Toremifene interacts with and destabilizes the Ebola virus glycoprotein
- (2016) Yuguang Zhao et al. NATURE
- Pioneering apoptosis-targeted cancer drug poised for FDA approval
- (2016) Asher Mullard NATURE REVIEWS DRUG DISCOVERY
- Small molecules, big targets: drug discovery faces the protein–protein interaction challenge
- (2016) Duncan E. Scott et al. NATURE REVIEWS DRUG DISCOVERY
- Overcoming Chemical, Biological, and Computational Challenges in the Development of Inhibitors Targeting Protein-Protein Interactions
- (2015) Luca Laraia et al. CHEMISTRY & BIOLOGY
- TNF Superfamily Protein-Protein Interactions: Feasibility of Small- Molecule Modulation
- (2015) Yun Song et al. CURRENT DRUG TARGETS
- Small-molecule modulators of the OX40-OX40 ligand co-stimulatory protein-protein interaction
- (2014) Yun Song et al. BRITISH JOURNAL OF PHARMACOLOGY
- Modulators of Protein–Protein Interactions
- (2014) Lech-Gustav Milroy et al. CHEMICAL REVIEWS
- Effects of Human Anti-Spike Protein Receptor Binding Domain Antibodies on Severe Acute Respiratory Syndrome Coronavirus Neutralization Escape and Fitness
- (2014) J. Sui et al. JOURNAL OF VIROLOGY
- Chemistry: Chemical con artists foil drug discovery
- (2014) Jonathan Baell et al. NATURE
- Targeting Membrane-Bound Viral RNA Synthesis Reveals Potent Inhibition of Diverse Coronaviruses Including the Middle East Respiratory Syndrome Virus
- (2014) Anna Lundin et al. PLoS Pathogens
- Current challenges in peptide-based drug discovery
- (2014) Laszlo Otvos et al. Frontiers in Chemistry
- Novel Inhibitors of Severe Acute Respiratory Syndrome Coronavirus Entry That Act by Three Distinct Mechanisms
- (2013) A. O. Adedeji et al. JOURNAL OF VIROLOGY
- ABT-199, a potent and selective BCL-2 inhibitor, achieves antitumor activity while sparing platelets
- (2013) Andrew J Souers et al. NATURE MEDICINE
- Structure of the CCR5 Chemokine Receptor-HIV Entry Inhibitor Maraviroc Complex
- (2013) Q. Tan et al. SCIENCE
- Patient preferences and willingness to pay for different options of anticoagulant therapy
- (2012) Marco Moia et al. Internal and Emergency Medicine
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- The food colorant erythrosine is a promiscuous protein–protein interaction inhibitor
- (2011) Lakshmi Ganesan et al. BIOCHEMICAL PHARMACOLOGY
- Synthesis and evaluation of non-basic inhibitors of urokinase-type plasminogen activator (uPA)
- (2011) Muthusamy Venkatraj et al. BIOORGANIC & MEDICINAL CHEMISTRY
- “Lest we forget you — methylene blue …”
- (2011) R. Heiner Schirmer et al. NEUROBIOLOGY OF AGING
- Small-molecule protein-protein interaction inhibitors: Therapeutic potential in light of molecular size, chemical space, and ligand binding efficiency considerations
- (2010) Peter Buchwald IUBMB LIFE
- Designing Focused Chemical Libraries Enriched in Protein-Protein Interaction Inhibitors using Machine-Learning Methods
- (2010) Christelle Reynès et al. PLoS Computational Biology
- Suramin inhibits the CD40–CD154 costimulatory interaction: A possible mechanism for immunosuppressive effects
- (2009) Emilio Margolles-Clark et al. BIOCHEMICAL PHARMACOLOGY
- Rationalizing the chemical space of protein–protein interaction inhibitors
- (2009) Olivier Sperandio et al. DRUG DISCOVERY TODAY
- Small-molecule costimulatory blockade: organic dye inhibitors of the CD40–CD154 interaction
- (2009) Emilio Margolles-Clark et al. JOURNAL OF MOLECULAR MEDICINE-JMM
- The spike protein of SARS-CoV — a target for vaccine and therapeutic development
- (2009) Lanying Du et al. NATURE REVIEWS MICROBIOLOGY
- Toward a cure for type 1 diabetes mellitus: diabetes-suppressive dendritic cells and beyond
- (2008) Nick Giannoukakis et al. PEDIATRIC DIABETES
- Protein therapeutics: a summary and pharmacological classification
- (2007) Benjamin Leader et al. NATURE REVIEWS DRUG DISCOVERY
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search